SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Beneish M-Score: -2.00 (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920199 SiChuan Qian Li Beoka Medical Technology Co Ltd BJSE:920199
57 GF Score
Price ¥27.12
GF Value ¥17.97
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is SiChuan Qian Li Beoka Medical Technology Co Beneish M-Score?

SiChuan Qian Li Beoka Medical Technology Co BJSE:920199 57 Beneish M-Score is -2.00 as of Aug. 19, 2026. GuruFocus rates BJSE:920199 with a GF Score™ of 57/100 and a GF Value™ of ¥17.97 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 768 Medical Devices & Instruments companies, SiChuan Qian Li Beoka Medical Technology Co ranks worse than 80.47% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for SiChuan Qian Li Beoka Medical Technology Co's Beneish M-Score or its related term are showing as below:

BJSE:920199' s Beneish M-Score Range Over the Past 10 Years
Min: -2.8   Med: -2.17   Max: 4.2
Current: -2

During the past 12 years, the highest Beneish M-Score of SiChuan Qian Li Beoka Medical Technology Co was 4.20. The lowest was -2.80. And the median was -2.17.


SiChuan Qian Li Beoka Medical Technology Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for SiChuan Qian Li Beoka Medical Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SiChuan Qian Li Beoka Medical Technology Co Beneish M-Score Chart

SiChuan Qian Li Beoka Medical Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1.21 -2.42 -2.62 -2.01

SiChuan Qian Li Beoka Medical Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.54 -2.49 -2.11 -2.01 -2.00

BJSE:920199 vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, SiChuan Qian Li Beoka Medical Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SiChuan Qian Li Beoka Medical Technology Co Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SiChuan Qian Li Beoka Medical Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SiChuan Qian Li Beoka Medical Technology Co's Beneish M-Score falls into.


BJSE:920199
57GF Score
SiChuan Qian Li Beoka Medical Technology Co Ltd BJSE:920199
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SiChuan Qian Li Beoka Medical Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SiChuan Qian Li Beoka Medical Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1885+0.528 * 1.0351+0.404 * 1.9263+0.892 * 0.9346+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0408+4.679 * -0.001179-0.327 * 1.0361
=-2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥48.1 Mil.
Revenue was 50.738 + 85.842 + 72.521 + 63.801 = ¥272.9 Mil.
Gross Profit was 20.008 + 28.146 + 28.698 + 22.401 = ¥99.3 Mil.
Total Current Assets was ¥281.2 Mil.
Total Assets was ¥693.6 Mil.
Property, Plant and Equipment(Net PPE) was ¥369.2 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥46.9 Mil.
Total Current Liabilities was ¥116.9 Mil.
Long-Term Debt & Capital Lease Obligation was ¥43.2 Mil.
Net Income was 0.546 + 0.625 + 9.854 + -4.878 = ¥6.1 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was -14.765 + 4.417 + 2.133 + 15.18 = ¥7.0 Mil.
Total Receivables was ¥43.3 Mil.
Revenue was 50.937 + 90.821 + 83.039 + 67.203 = ¥292.0 Mil.
Gross Profit was 17.543 + 32.269 + 33.39 + 26.728 = ¥109.9 Mil.
Total Current Assets was ¥328.9 Mil.
Total Assets was ¥670.8 Mil.
Property, Plant and Equipment(Net PPE) was ¥320.2 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥48.2 Mil.
Total Current Liabilities was ¥109.6 Mil.
Long-Term Debt & Capital Lease Obligation was ¥39.9 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(48.082 / 272.902) / (43.288 / 292)
=0.176188 / 0.148247
=1.1885

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(109.93 / 292) / (99.253 / 272.902)
=0.376473 / 0.363695
=1.0351

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (281.167 + 369.209) / 693.604) / (1 - (328.929 + 320.183) / 670.816)
=0.062324 / 0.032355
=1.9263

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=272.902 / 292
=0.9346

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 320.183)) / (0 / (0 + 369.209))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(46.928 / 272.902) / (48.246 / 292)
=0.171959 / 0.165226
=1.0408

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((43.223 + 116.927) / 693.604) / ((39.851 + 109.635) / 670.816)
=0.230895 / 0.222842
=1.0361

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(6.147 - 0 - 6.965) / 693.604
=-0.001179

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SiChuan Qian Li Beoka Medical Technology Co has a M-score of -2.00 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.00 mean?
SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) has a Beneish M-Score of -2.00 as of Aug. 19, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors. According to the industry distribution chart, SiChuan Qian Li Beoka Medical Technology Co ranks #618 out of 768 companies in the Medical Devices & Instruments industry, placing it in the top 80.5%.
Is SiChuan Qian Li Beoka Medical Technology Co's Beneish M-Score too high?
SiChuan Qian Li Beoka Medical Technology Co's current Beneish M-Score is -2.00. Based on the distribution chart, SiChuan Qian Li Beoka Medical Technology Co ranks #618 out of 768 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SiChuan Qian Li Beoka Medical Technology Co has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SiChuan Qian Li Beoka Medical Technology Co's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SiChuan Qian Li Beoka Medical Technology Co ranks #618 out of 768 companies for Beneish M-Score. This places SiChuan Qian Li Beoka Medical Technology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SiChuan Qian Li Beoka Medical Technology Co and its competitors. SiChuan Qian Li Beoka Medical Technology Co's current Beneish M-Score is -2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SiChuan Qian Li Beoka Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.97, compared to a current price of ¥27.12 — trading 50.9% above its estimated fair value. The current Beneish M-Score is -2.00. SiChuan Qian Li Beoka Medical Technology Co's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199), the current Beneish M-Score is -2.00 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SiChuan Qian Li Beoka Medical Technology Co (BJSE:920199) Overvalued in 2026?

Based on GuruFocus' analysis, SiChuan Qian Li Beoka Medical Technology Co stock appears to be overvalued. The current stock price of ¥27.12 is trading 50.9% above its estimated GF Value™ of ¥17.97. GuruFocus considers SiChuan Qian Li Beoka Medical Technology Co to be Significantly Overvalued.

Key valuation signals for BJSE:920199:

  • Beneish M-Score: -2.00
  • GF Value™: ¥17.97 vs. price of ¥27.12 (50.9% above fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the BJSE:920199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SiChuan Qian Li Beoka Medical Technology Co Business Description

Address East Third Ring Road, Longtan Industrial Park, Section 2, Chenghua District, Sichuan Province, Chengdu City, CHN, 610052
SiChuan Qian Li Beoka Medical Technology Co Ltd is an intelligent rehabilitation equipment manufacturer integrating research, development, production, sales, and service. Its product series comprises the Electrotherapy series, Heat therapy series, Force therapy series, Spa series, and Oxygen therapy series.
57GF Score

Get the complete analysis for BJSE:920199

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.12
Price
¥17.97
GF Value